15 publications
| Name | Date | Type | Actions |
|---|---|---|---|
2024 Calendar of financial communication Vetoquinol published its calendar of financial communication for 2024. |
03/01/2024 | Agenda | |
ANNUAL RESULTS 2023 (slideshow) 01.2023 Highlights |
20/03/2024 | Annual Report | |
Buyback programs – January 2024 Monthly communication regarding buyback programs |
02/02/2024 | Description of buyback programs | |
Buyback programs - March 2024 Monthly communication regarding buyback programs |
04/04/2024 | Description of buyback programs | |
Annual sales 2023: €529 million Annual Sales of Essential products: €313 million (up 4.5% at constant exchange rates) |
24/01/2024 | Public releases | |
Availability of the 2023 universal registration document On 24 April 2024, Vetoquinol filed its 2022 Universal Registration Document with the Autorité des Marchés Financiers (AMF) in ESEF (European Single Electronic Format). |
24/04/2024 | Public releases | |
2023 ANNUAL RESULTS Annual sales: €529m (stable at constant exchange rates) |
20/03/2024 | Public releases | |
SALES 1st quarter 2024: €134M The Vetoquinol Group recorded sales of €133.7 million in the 1st quarter of fiscal 2024, including €83.4 million for Essential products. |
29/04/2024 | Public releases | |
Universal registration document 2023 XBRL version Universal Registration Document including the Annual Financial Report |
24/04/2024 | Reference document | |
Universal registration document 2023 Universal Registration Document including the Annual Financial Report |
24/04/2024 | Reference document |